Studies have showed that S100A9 treatment enhanced the survival and invasiveness of three hepatoma cell lines, HepG2, SMMC-7721, and Huh7, and S100A9 also facilitated tumor development in vivo in a xenograft mouse model. The gene discussed is S100A9; the disease is neoplasm.